SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) are major infectious causes of death,
with meta-analyses and population-based studies finding increased mortality in co-infected …

Mycobacterium tuberculosis (M. tb) and SARS-CoV-2 are both infections that can lead to
severe disease in the lower lung. However, these two infections are caused by very different …

Abstract Summary background The coronavirus 2019 pandemic was caused by a new
single-strand RNA virus that originated from Wuhan, China, and infected more than 190 …

At the beginning of the COVID-19 pandemic those with underlying chronic lung conditions,
including tuberculosis (TB), were hypothesized to be at higher risk of severe COVID-19 …

Background Data on the coincidence of Tuberculosis (TB) and Coronavirus disease 2019
(COVID-19) are limited. We sought to investigate the clinical characteristics and outcomes of …

Background COVID-19 pandemic has disrupted tuberculosis (TB) services in many
countries, but the impacts on sites of involvement, drug susceptibility, smear positivity and …

Antifungal resistance poses a significant challenge to disease management, necessitating
the development of novel drugs. Antimicrobial peptides offer potential solutions. This study …

The study proposes a dynamic spatio‐temporal profile of the distribution of tuberculosis
incidence and air pollution in Romania, where this infectious disease induces more than …

To investigate how structural modifications affect tuberculostatic potency, we synthesized
seven new piperidinothiosemicrabazone derivatives 8–14, in which three of them had a …

Background and Objectives: The concurrent occurrence of tuberculosis and COVID-19
coinfection poses significant clinical complexities, warranting a nuanced approach to …